Top Markets
Coin of the day
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Rang in Aktien #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Aktienkurs
$0.71707249
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$94.14M
Veränderung (1 Tag)
-3.31%
Veränderung (1 Jahr)
76.82%
Land
SE
Handel AlzeCure Pharma AB (ALZCUR)

Kategorie

EPS für AlzeCure Pharma AB (ALZCUR)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von AlzeCure Pharma AB beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von AlzeCure Pharma AB von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH